$9.165
-0.715 (-7.80%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
STRO-Prognose durch Analyse ähnlicher Charts
Alphio's STRO stock price prediction model matches the current Sutro Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.10 (-1.04%). The 1-week path is $9.47 (+2.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Sutro Biopharma Inc-Aktien kaufen?
Sutro Biopharma Inc is currently a hold. The stock is trading at $9.11, significantly below its 52-week high of $43.85, indicating a potential for recovery. However, the RSI is at 26.36, suggesting it is oversold, and the forward P/E ratio is 10.03, indicating that while the stock may be undervalued, the company is still facing substantial financial losses, with a net income loss of $38.5 million reported in Q2 2026. The main risk is the declining revenue trend, with a 39.79% drop over the last 20 days, which raises concerns about the company's short-term performance.
STRO schloss am Thursday bei $9.17, nachdem der Kurs -7.80% fallen
Sutro Biopharma Inc (STRO) last closed at $9.1999998, losing -7.44%. These facts feed the 1-day and 1-week STRO price prediction above.
Analystenkonsens
Sutro Biopharma Inc (STRO): 4 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Sutro Biopharma Inc (STRO) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf STRO am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für STRO
Historically the probability of a positive November return for STRO is 0.00%. February offers the highest probability of a positive month at 58.62%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für STRO
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $0.77 | $0.80 | $0.91 | -91.33% |
| Dec 2026 | $0.66 | $0.80 | $0.93 | -91.33% |
Für 2026 wird für Sutro Biopharma Inc (STRO) eine Spanne von $0.66 bis $0.93 projiziert.
Monatsprognose 2026 für Sutro Biopharma Inc
Im Nov 2026 wird für Sutro Biopharma Inc ein Durchschnitt von $0.80 erwartet, mit einem Tief von $0.77 und einem Hoch von $0.91.
Im Dec 2026 wird für Sutro Biopharma Inc ein Durchschnitt von $0.80 erwartet, mit einem Tief von $0.66 und einem Hoch von $0.93.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.